A new oral inactivated cholera vaccine, Euvichol-S, has been added to the WHO's list of prequalified vaccines, the World Health Organization (WHO) said in a press release on the 18th. This is the third oral cholera vaccine to enter the WHO prequalification list.
世界卫生组织18日发布新闻公报称，新款口服灭活霍乱疫苗Euvichol-S日前已被列入世卫组织资格预审疫苗清单中。这是进入世卫组织资格预审清单的第三款口服霍乱疫苗。
The WHO says the vaccine is similar in efficacy to existing vaccines, but has a simplified formulation that gives it the opportunity to rapidly increase production capacity. The vaccine is produced by South Korean company EuBiologicals, which has previously prequalified its two oral inactivated cholera vaccines, Euvichol and Euvichol-Plus.
世卫组织说，该款疫苗功效与现有疫苗相似，但配方简化，因此有机会迅速提高产能。这款疫苗由韩国EuBiologicals公司生产，此前该公司生产的Euvichol和Euvichol-Plus两款口服灭活霍乱疫苗已获得资格预审。
Vaccines are the fastest intervention to prevent and control cholera outbreaks, but vaccine supplies have been at their lowest point in situations where countries have serious shortcomings in cholera prevention and management, including safe water, hygiene and sanitation, the WHO said.
世卫组织说，疫苗是预防和控制霍乱暴发的最快干预手段，但各国在安全用水、个人卫生和环境卫生等霍乱预防和管理方面存在严重短板情况下，疫苗供应却一直处于最低点。
The number of cholera cases reported to WHO worldwide in 2022 was 473,000, more than double the number reported in 2021. Preliminary statistics show that the number of cholera cases globally continues to increase in 2023.
2022年全球各地向世卫组织报告的霍乱病例数为47.3万例，是2021年报告病例数的两倍多。初步统计数据显示，2023年全球霍乱病例数继续增加。
世界卫生组织18日发布新闻公报称，新款口服灭活霍乱疫苗Euvichol-S日前已被列入世卫组织资格预审疫苗清单中。这是进入世卫组织资格预审清单的第三款口服霍乱疫苗。
The WHO says the vaccine is similar in efficacy to existing vaccines, but has a simplified formulation that gives it the opportunity to rapidly increase production capacity. The vaccine is produced by South Korean company EuBiologicals, which has previously prequalified its two oral inactivated cholera vaccines, Euvichol and Euvichol-Plus.
世卫组织说，该款疫苗功效与现有疫苗相似，但配方简化，因此有机会迅速提高产能。这款疫苗由韩国EuBiologicals公司生产，此前该公司生产的Euvichol和Euvichol-Plus两款口服灭活霍乱疫苗已获得资格预审。
Vaccines are the fastest intervention to prevent and control cholera outbreaks, but vaccine supplies have been at their lowest point in situations where countries have serious shortcomings in cholera prevention and management, including safe water, hygiene and sanitation, the WHO said.
世卫组织说，疫苗是预防和控制霍乱暴发的最快干预手段，但各国在安全用水、个人卫生和环境卫生等霍乱预防和管理方面存在严重短板情况下，疫苗供应却一直处于最低点。
The number of cholera cases reported to WHO worldwide in 2022 was 473,000, more than double the number reported in 2021. Preliminary statistics show that the number of cholera cases globally continues to increase in 2023.
2022年全球各地向世卫组织报告的霍乱病例数为47.3万例，是2021年报告病例数的两倍多。初步统计数据显示，2023年全球霍乱病例数继续增加。
